Dolphin Medical Services Limited (BOM:526504)

Dolphin Medical Services Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Revenue	7.5	7.79	6.79	6.11	5.2
Other Revenue	0.37	0.37	0.37	0.37	0.37
Revenue	7.87	8.16	7.15	6.48	5.57
Revenue Growth (YoY)	-3.60%	14.10%	10.39%	16.31%	-90.75%
Cost of Revenue	2.52	2.71	2.78	2.42	2.21
Gross Profit	5.35	5.46	4.38	4.06	3.36
Selling, General & Admin	-	1.21	1.19	1.11	1.11
Other Operating Expenses	3.74	3.82	3.59	3.4	3.29
Operating Expenses	4.64	5.66	5.24	5.14	5.03
Operating Income	0.71	-0.21	-0.87	-1.08	-1.67
Interest Expense	-0.1	-0.1	-0.1	-0.09	-0.09
EBT Excluding Unusual Items	0.61	-0.3	-0.96	-1.18	-1.76
Pretax Income	0.61	-0.3	-0.96	-1.18	-1.76
Income Tax Expense	0.19	0.03	0.08	0.07	0.11
Net Income	0.42	-0.34	-1.04	-1.25	-1.87
Net Income to Common	0.42	-0.34	-1.04	-1.25	-1.87
Shares Outstanding (Basic)	21	17	15	16	16
Shares Outstanding (Diluted)	21	17	15	16	16
Shares Change (YoY)	23.96%	13.71%	-4.56%	-0.32%	5.08%
EPS (Basic)	0.02	-0.02	-0.07	-0.08	-0.12
EPS (Diluted)	0.02	-0.02	-0.07	-0.08	-0.12
Free Cash Flow	-3.18	-0.6	-0.45	-0.69	-0.99
Free Cash Flow Per Share	-0.15	-0.04	-0.03	-0.04	-0.06
Gross Margin	68.00%	66.83%	61.16%	62.65%	60.34%
Operating Margin	9.00%	-2.55%	-12.14%	-16.72%	-29.93%
Profit Margin	5.33%	-4.14%	-14.54%	-19.23%	-33.65%
Free Cash Flow Margin	-40.41%	-7.32%	-6.29%	-10.66%	-17.71%
EBITDA	1.61	0.42	-0.4	-0.46	-1.04
EBITDA Margin	20.46%	5.13%	-5.64%	-7.04%	-18.68%
D&A For EBITDA	0.9	0.63	0.47	0.63	0.63
EBIT	0.71	-0.21	-0.87	-1.08	-1.67
EBIT Margin	9.00%	-2.55%	-12.14%	-16.72%	-29.93%
Effective Tax Rate	31.54%	-	-	-	-
Revenue as Reported	7.87	8.16	7.15	6.48	5.57
Advertising Expenses	-	0.09	0.08	0.08	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.